These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 41040)

  • 21. The effect of some antirheumatic drugs in vivo on the response of spleen cells to concanavalin A in rats with chronic inflammation.
    Binderup L; Bramm E; Arrigoni-Martelli E
    Int J Immunopharmacol; 1982; 4(1):57-66. PubMed ID: 6806203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum sulphydryl concentrations and antirheumatic drugs in rheumatoid patients.
    Grimaldi MG
    J Pharm Pharmacol; 1980 Dec; 32(12):876. PubMed ID: 6110764
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes.
    Hurst NP; Bell AL; Nuki G
    Ann Rheum Dis; 1986 Jan; 45(1):37-43. PubMed ID: 3006610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of anti-arthritic gold compounds on mycoplasma and leishmania.
    Berkoff CE; Actor P; Sutton BM; Walz DT; Klinikowski N
    Arzneimittelforschung; 1974 Dec; 24(12):1988-90. PubMed ID: 4217631
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro penicillamine competition for protein-bound gold(I).
    Schaeffer N; Shaw CF; Thompson HO; Satre RW
    Arthritis Rheum; 1980 Feb; 23(2):165-71. PubMed ID: 6767488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Slow onset anti-rheumatic drugs in rheumatoid arthritis: could the presence of antinuclear antibody influence the therapeutic results?
    Menard HA; Mathieu JP; de Medicis R; Lussier A
    J Rheumatol; 1979; 6(2):156-62. PubMed ID: 110929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the mechanism of action during treatment of rheumatoid arthritis with penicillamine and gold thiomalate the same?
    Jellum E; Aaseth J; Munthe E
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):136-9. PubMed ID: 122761
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug protein interactions.
    Chicault M; Luu Duc C; Boucherle A
    Arzneimittelforschung; 1981; 31(6):1015-20. PubMed ID: 7196231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibition of leukocyte collagenase and cathepsin G by anti-rheumatic drugs].
    Stancíková M; Trnavský K
    Fysiatr Revmatol Vestn; 1980 Aug; 58(4):189-92. PubMed ID: 6158471
    [No Abstract]   [Full Text] [Related]  

  • 30. Reducing property of some slow acting antirheumatic drugs.
    Huck F; de Médicis R; Lussier A; Dupuis G; Federlin P
    J Rheumatol; 1984 Oct; 11(5):605-9. PubMed ID: 6512791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP
    Can Med Assoc J; 1980 Feb; 122(4):405-15. PubMed ID: 6768438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The displacement of L-tryptophan and dipeptides from bovine albumin in vitro and from human plasma in vivo by antirheumatic drugs.
    McArthur JN; Dawkins PD; Smith MJ
    J Pharm Pharmacol; 1971 Jun; 23(6):393-8. PubMed ID: 4397176
    [No Abstract]   [Full Text] [Related]  

  • 33. Protein sulphydryl depression during adjuvant arthritis.
    Lorber A; Leeb J; Carroll P; Baumgartner W; Hill V
    Ann Rheum Dis; 1975 Aug; 34(4):346-9. PubMed ID: 1190854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gold and penicillamine: a proposed mode of action in rheumatoid arthritis, based on synovial fluid analysis.
    Pritchard MH; Nuki G
    Ann Rheum Dis; 1978 Dec; 37(6):493-503. PubMed ID: 107867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease-modifying agents in rheumatoid arthritis.
    Lipsky PE
    Ryumachi; 1987 Dec; 27(6):409-12. PubMed ID: 2455354
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacology of collagen].
    Trnavský K
    Cas Lek Cesk; 1981 Feb; 120(8):209-11. PubMed ID: 7214447
    [No Abstract]   [Full Text] [Related]  

  • 37. Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study.
    Veys EM; Mielants H; Verbruggen G
    Clin Exp Rheumatol; 1987; 5(2):111-6. PubMed ID: 3608266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gold concentrations in blood fractions of patients with rheumatoid arthritis treated with Myocrisin.
    Egila J; Littlejohn D; Smith WE; Sturrock RD
    J Pharm Biomed Anal; 1992 Sep; 10(9):639-44. PubMed ID: 1286129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulphydryl dependence of the inhibition of mitogen-induced human lymphocyte proliferation by sodium aurothiomalate.
    McCormack PL; Palmer DG
    Biochem Pharmacol; 1980 Dec; 29(24):3333-6. PubMed ID: 6783048
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma zinc and its relationship to clinical symptoms and drug treatment in rheumatoid arthritis.
    Balogh Z; El-Ghobarey AF; Fell GS; Brown DH; Dunlop J; Dick WC
    Ann Rheum Dis; 1980 Aug; 39(4):329-32. PubMed ID: 7436558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.